Page last updated: 2024-11-06

benzimidazole and Hyperuricemia

benzimidazole has been researched along with Hyperuricemia in 1 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.

Research Excerpts

ExcerptRelevanceReference
"Currently, the treatment of gout mainly includes two basic methods: reducing uric acid and alleviating inflammation."1.56Development of novel NLRP3-XOD dual inhibitors for the treatment of gout. ( Ha, EH; Hu, Q; Li, H; Li, Z; Pang, J; Tian, S; Wang, W; Zhou, M, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, W1
Pang, J1
Ha, EH1
Zhou, M1
Li, Z1
Tian, S1
Li, H1
Hu, Q1

Other Studies

1 other study available for benzimidazole and Hyperuricemia

ArticleYear
Development of novel NLRP3-XOD dual inhibitors for the treatment of gout.
    Bioorganic & medicinal chemistry letters, 2020, 02-15, Volume: 30, Issue:4

    Topics: Animals; Benzimidazoles; Benzoxazoles; Cell Line; Disease Models, Animal; Gout; Humans; Hyperuricemi

2020